{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:24:57Z","timestamp":1790720697710,"version":"4.1.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472344, 82372316"],"award-info":[{"award-number":["82472344, 82372316"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2025J09037"],"award-info":[{"award-number":["2025J09037"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic hepatitis B (CHB) and metabolic dysfunction-associated steatotic liver disease (MASLD) frequently coexist and synergistically accelerate progression to end-stage liver disease. However, the metabolic differences distinguishing CHB alone from CHB with MASLD remain poorly defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Serum samples from 47 CHB patients with or without MASLD were analyzed as a discovery set using widely targeted metabolomics. An independent validation set of 94 samples was subsequently examined with targeted metabolomics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CHB patients with MASLD showed marked alterations in amino acid metabolism compared to those with CHB alone. Analysis revealed 206 significantly altered metabolites, among which amino acids represented the largest altered subgroup. Targeted quantification validated nine amino acids significantly upregulated in CHB-MASLD patients: leucine, tryptophan, phenylalanine, tyrosine, glutamic acid, alanine, histidine, lysine, and 2-aminoadipate. These 9 differential amino metabolites (9-DAM) robustly discriminated CHB with MASLD from CHB alone, achieving AUCs of 0.889 and 0.918 in the discovery and validation sets, respectively. The 9-DAM panel consistently outperformed controlled attenuation parameters (CAP) and correlated positively with CAP and liver stiffness measurements.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CHB patients with MASLD exhibit a distinct disruption of circulating amino acid metabolism, reflecting unique metabolomic signatures. These findings highlight promising biomarkers and the pathophysiological significance of this comorbidity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2026.1783221","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:55:29Z","timestamp":1777442129000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrated metabolomics analysis identifies distinct amino acid signatures in chronic hepatitis B patients with metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.3389","volume":"16","author":[{"given":"Yanping","family":"Lan","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Fujian Key Laboratory of Laboratory Medicine, Gene Diagnosis Research Center, Fujian Clinical Research Center for Clinical Immunology Laboratory Test, The First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zitao","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Fujian Key Laboratory of Laboratory Medicine, Gene Diagnosis Research Center, Fujian Clinical Research Center for Clinical Immunology Laboratory Test, The First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunfang","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Fujian Key Laboratory of Laboratory Medicine, Gene Diagnosis Research Center, Fujian Clinical Research Center for Clinical Immunology Laboratory Test, The First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Fujian Key Laboratory of Laboratory Medicine, Gene Diagnosis Research Center, Fujian Clinical Research Center for Clinical Immunology Laboratory Test, The First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrong","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Fujian Key Laboratory of Laboratory Medicine, Gene Diagnosis Research Center, Fujian Clinical Research Center for Clinical Immunology Laboratory Test, The First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renquan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Fujian Key Laboratory of Laboratory Medicine, Gene Diagnosis Research Center, Fujian Clinical Research Center for Clinical Immunology Laboratory Test, The First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, Fujian, China"]},{"name":"Department of Laboratory Medicine, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujue","family":"He","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Fujian Key Laboratory of Laboratory Medicine, Gene Diagnosis Research Center, Fujian Clinical Research Center for Clinical Immunology Laboratory Test, The First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, Fujian, China"]},{"name":"Department of Laboratory Medicine, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyao","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Fujian Key Laboratory of Laboratory Medicine, Gene Diagnosis Research Center, Fujian Clinical Research Center for Clinical Immunology Laboratory Test, The First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detai","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Fujian Key Laboratory of Laboratory Medicine, Gene Diagnosis Research Center, Fujian Clinical Research Center for Clinical Immunology Laboratory Test, The First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Fujian Key Laboratory of Laboratory Medicine, Gene Diagnosis Research Center, Fujian Clinical Research Center for Clinical Immunology Laboratory Test, The First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Fujian Key Laboratory of Laboratory Medicine, Gene Diagnosis Research Center, Fujian Clinical Research Center for Clinical Immunology Laboratory Test, The First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, Fujian, China"]},{"name":"Department of Laboratory Medicine, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qishui","family":"Ou","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Fujian Key Laboratory of Laboratory Medicine, Gene Diagnosis Research Center, Fujian Clinical Research Center for Clinical Immunology Laboratory Test, The First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, Fujian, China"]},{"name":"Department of Laboratory Medicine, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Xun","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Fujian Key Laboratory of Laboratory Medicine, Gene Diagnosis Research Center, Fujian Clinical Research Center for Clinical Immunology Laboratory Test, The First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, Fujian, China"]},{"name":"Department of Laboratory Medicine, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-025-00780-3","article-title":"Deep proteome profiling of metabolic dysfunction-associated steatotic liver disease","volume":"5","author":"Boel","year":"2025","journal-title":"Commun. Med."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2203894119","article-title":"Gut flora disequilibrium promotes the initiation of liver cancer by modulating tryptophan metabolism and up-regulating SREBP2","volume":"119","author":"Chen","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1038\/s41401-025-01495-w","article-title":"Cannabinoid-2 receptor depletion promotes non-alcoholic fatty liver disease in mice via disturbing gut microbiota and tryptophan metabolism","volume":"46","author":"Cheng","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"key":"B4","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S2468-1253(22)00386-7","article-title":"Global reporting of progress towards elimination of hepatitis B and hepatitis C","volume":"8","author":"Cui","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2024.109581","article-title":"Molecular mechanism and therapeutic significance of essential amino acids in metabolically associated fatty liver disease","volume":"126","author":"Deng","year":"2024","journal-title":"J. Nutr. Biochem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"955","DOI":"10.14218\/JCTH.2024.00311","article-title":"Guideline for the prevention and treatment of metabolic dysfunction-associated fatty liver disease (Version 2024)","volume":"12","author":"Fan","year":"2024","journal-title":"J. Clin. Transl. Hepatol."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/nu12051450","article-title":"Changed amino acids in NAFLD and liver fibrosis: A large cross-sectional study without influence of insulin resistance","volume":"12","author":"Hasegawa","year":"2020","journal-title":"Nutrients"},{"key":"B8","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.cgh.2023.09.040","article-title":"Metabolic dysfunction-associated steatotic liver disease facilitates hepatitis B surface antigen seroclearance and seroconversion","volume":"22","author":"Huang","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/apt.16706","article-title":"Increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis with concurrent fatty liver","volume":"55","author":"Kim","year":"2022","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2025.101414","article-title":"Inflammation in MASLD progression and cancer","volume":"7","author":"Kim","year":"2025","journal-title":"JHEP Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cmet.2024.09.009","article-title":"Non-invasive lipid panel of MASLD fibrosis transition underscores the role of lipoprotein sulfatides in hepatic immunomodulation","volume":"37","author":"Lam","year":"2025","journal-title":"Cell Metab."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2025.101391","article-title":"Prediction of long-term HBsAg seroclearance in patients with HBeAg-negative chronic hepatitis B","volume":"7","author":"Lee","year":"2025","journal-title":"JHEP Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1016\/j.cmet.2024.10.001","article-title":"Amino acid is a major carbon source for hepatic lipogenesis","volume":"36","author":"Liao","year":"2024","journal-title":"Cell Metab."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2024.1347459","article-title":"Metabolic dysfunction-associated steatotic liver disease increases hepatocellular carcinoma risk in chronic hepatitis B patients: A retrospective cohort study","volume":"15","author":"Lin","year":"2024","journal-title":"Front. Physiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00125-017-4222-6","article-title":"Genetic evidence of a causal effect of insulin resistance on branched-chain amino acid levels","volume":"60","author":"Mahendran","year":"2017","journal-title":"Diabetologia"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1136\/gut.19.11.1068","article-title":"Plasma ratio of valine, leucine and isoleucine to phenylalanine and tyrosine in liver disease","volume":"19","author":"Morgan","year":"1978","journal-title":"Gut"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2025.101477","article-title":"All-cause and disease-specific mortality in young adults with MASLD: A nationwide cohort study","volume":"7","author":"Park","year":"2025","journal-title":"JHEP Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cgh.2022.06.013","article-title":"AGILE 3+ score for the diagnosis of advanced fibrosis and for predicting liver-related events in NAFLD","volume":"21","author":"Pennisi","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"B19","doi-asserted-by":"publisher","first-page":"827","DOI":"10.14218\/JCTH.2024.00048","article-title":"The reduced accuracy of non-invasive tests for significant fibrosis in chronic hepatitis B patients with metabolic dysfunction-associated steatotic liver disease","volume":"12","author":"Rui","year":"2024","journal-title":"J. Clin. Transl. Hepatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1016\/j.cgh.2024.06.014","article-title":"Machine learning\u2013based models for advanced fibrosis and cirrhosis diagnosis in chronic hepatitis B patients with hepatic steatosis","volume":"22","author":"Rui","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2025.101507","article-title":"Effectiveness and active ingredients of digital behaviour change interventions for MASLD: A systematic review and meta-analysis","volume":"7","author":"Smith","year":"2025","journal-title":"JHEP Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S0140-6736(76)90541-9","article-title":"Insulin, glucagon, aminoacid imbalance, and hepatic encephalopathy","volume":"308","author":"Soeters","year":"1976","journal-title":"Lancet"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101853","article-title":"Metabolomics at the cutting edge of risk prediction of MASLD","volume":"5","author":"Tan","year":"2024","journal-title":"Cell Rep. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"101535","DOI":"10.1016\/j.jhepr.2025.101535","article-title":"Mildly elevated liver lipid content is characterised by reduced insulin sensitivity","author":"Tuomola","year":"2025","journal-title":"JHEP Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.cmet.2025.02.008","article-title":"Pyruvate metabolism enzyme DLAT promotes tumorigenesis by suppressing leucine catabolism","volume":"37","author":"Wang","year":"2025","journal-title":"Cell Metab."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101080","article-title":"Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis","volume":"42","author":"Winther-S\u00f8rensen","year":"2020","journal-title":"Mol. Metab."},{"key":"B27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.14218\/JCTH.2022.00066","article-title":"Adverse effect of nonalcoholic fatty liver disease on the therapeutic response in patients with chronic hepatitis B","volume":"11","author":"Zhang","year":"2022","journal-title":"J. Clin. Transl. Hepatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0304-5","article-title":"Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats","volume":"51","author":"Zhao","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1111\/apt.16595","article-title":"Systematic review with meta-analysis: Prevalence of hepatic steatosis, fibrosis and associated factors in chronic hepatitis B","volume":"54","author":"Zheng","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1038\/s41467-022-32000-0","article-title":"Phenylalanine impairs insulin signaling and inhibits glucose uptake through modification of IR\u03b2","volume":"13","author":"Zhou","year":"2022","journal-title":"Nat. Commun."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000672","article-title":"Single-cell profiling reveals monocyte heterogeneity and association with liver fibrosis in patients with chronic HBV","volume":"9","author":"Zhuo","year":"2025","journal-title":"Hepatol. Commun."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1783221\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:55:30Z","timestamp":1777442130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1783221\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":31,"alternative-id":["10.3389\/fcimb.2026.1783221"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1783221","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"article-number":"1783221"}}